Evercore ISI analyst Elizabeth Anderson lowered the firm’s price target on Dentsply Sirona (XRAY) to $13 from $17 and keeps an In Line rating on the shares as the firm updates estimates and makes several tactical calls in the Healthcare Technology & Distribution group ahead of Q3 earnings season.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- DENTSPLY SIRONA Announces Leadership Transition for Rosenzweig
- Dentsply Sirona appoints Denti as Chief Commercial Officer
- Cautious Hold Rating on DENTSPLY SIRONA Amid Awaited Turnaround Evidence
- DENTSPLY SIRONA Approves Retention Award for Executives
- Hold Rating for DENTSPLY SIRONA Amid Strategic Retention of Wellspect and Focus on Core Dental Business Revitalization